PNB reduces gold loan rates
Punjab National Bank (PNB) now offers loans against Sovereign Gold Bond (SGB) at 7.20 per cent and loans against gold jewellery at 7.30 per cent, the bank said in a statement.
State-owned Punjab National Bank (PNB) on Wednesday slashed the interest rate on loans against gold jewellery and Sovereign Gold Bond by 145 basis points or 1.45 percentage points as part of its festive offer.
PNB now offers loans against Sovereign Gold Bond (SGB) at 7.20 per cent and loans against gold jewellery at 7.30 per cent, the bank said in a statement.
See Zee Business Live TV Streaming Below:
Additionally, it said, PNB has slashed the home loan rate which now starts from 6.60 per cent, while customers can avail car loans starting from 7.15 per cent and personal loans from 8.95 per cent, one of the lowest in the industry.
During the festive season, PNB is also offering a full waiver of service charges/processing fee on the loans against gold jewellery and SGB, similar to home loans and vehicle loans announced recently.
The bank has also slashed the margin on home loans and the borrower can now avail of loans up to 80 per cent of the property's value without any upper ceiling on the loan amount, it said.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SBI Latest FD Rates: PSU bank pays these returns to senior citizens and other depositors on 1-year, 3-year and 5-year fixed deposits
Largecap PSU Stock for 65% Gain in New Year: Anil Singhvi picks PSU bank for long term; know reasons and target prices
Vande Bharat Sleeper Trial: Railway Minister Ashwini Vaishnaw shares video of train running at 180 kmph
Top 7 Index Mutual Funds With Best SIP Returns in 10 Years: Rs 11,111 monthly SIP investment in No. 1 fund is now worth Rs 33,18,831; know how others have fared
SIP Stock Pick For New Year 2025: Anil Singhvi recommends buying this largecap pharma stock on 10% dip
05:48 PM IST